{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:29:15Z","timestamp":1790152155161,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Accumulating evidence suggests that inflammation plays an important role in the progression of Parkinson's disease (PD). Among many inflammatory factors found in the PD brain, cyclooxygenase (COX), specifically the inducible isoform, COX-2, is believed to be a critical enzyme in the inflammatory response. Induction of COX-2 is also found in an experimental model of PD produced by administration of 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>COX-2-deficient mice or C57BL\/6 mice were treated with MPTP to investigate the effects of COX-2 deficiency or by using various doses of valdecoxib, a specific COX-2 inhibitor, which induces inhibition of COX-2 on dopaminergic neuronal toxicity and locomotor activity impairment. Immunohistochemistry, stereological cell counts, immunoblotting, an automated spontaneous locomotor activity recorder and rotarod behavioral testing apparatus were used to assess microglial activation, cell loss, and behavioral impariments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MPTP reduced tyrosine hydroxylase (TH)-positive cell counts in the substantia nigra<jats:italic>pars compacta<\/jats:italic>(SNpc); total distance traveled, vertical activity, and coordination on a rotarod; and increased microglia activation. Valdecoxib alleviated the microglial activation, the loss of TH-positive cells and the decrease in open field and vertical activity. COX-2 deficiency attenuated MPTP-induced microglial activation, degeneration of TH-positive cells, and loss of coordination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These results indicate that reducing COX-2 activity can mitigate the secondary and progressive loss of dopaminergic neurons as well as the motor deficits induced by MPTP, possibly by suppression of microglial activation in the SNpc.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1742-2094-3-6","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T12:49:52Z","timestamp":1144327792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":201,"title":["Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease"],"prefix":"10.1186","volume":"3","author":[{"given":"Rattanavijit","family":"Vijitruth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan V","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy L","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,27]]},"reference":[{"key":"59_CR1","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.0837397100","volume":"100","author":"P Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Choi DK, Wu DC, Naini A, Hunot S, Vila M, Jackson-Lewis V, Przedborski S: Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. PNAS. 2003, 100: 5473-5478. 10.1073\/pnas.0837397100.","journal-title":"PNAS"},{"key":"59_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988, 38: 1285-1291.","journal-title":"Neurology"},{"key":"59_CR3","first-page":"3","volume":"50 Suppl 1","author":"B Samuelsson","year":"1991","unstructured":"Samuelsson B: Arachidonic acid metabolism: role in inflammation. Z Rheumatol. 1991, 50 Suppl 1: 3-6.","journal-title":"Z Rheumatol"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1002\/j.1875-9114.1997.tb03696.x","volume":"17","author":"SE Wenzel","year":"1997","unstructured":"Wenzel SE: Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy. 1997, 17: 3S-12S.","journal-title":"Pharmacotherapy"},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1016\/S0021-9258(18)98774-0","volume":"266","author":"DA Kujubu","year":"1991","unstructured":"Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase\/cyclooxygenase homologue. J Biol Chem. 1991, 266: 12866-12872.","journal-title":"J Biol Chem"},{"key":"59_CR6","first-page":"6","volume":"24 Suppl 49","author":"P Needleman","year":"1997","unstructured":"Needleman P, Isakson PC: The discovery and function of COX-2. J Rheumatol. 1997, 24 Suppl 49: 6-8.","journal-title":"J Rheumatol"},{"key":"59_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1021\/tx010004x","volume":"14","author":"D Nikolic","year":"2001","unstructured":"Nikolic D, van Breemen RB: DNA oxidation induced by cyclooxygenase-2. Chem Res Toxicol. 2001, 14: 351-354. 10.1021\/tx010004x.","journal-title":"Chem Res Toxicol"},{"key":"59_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1248\/bpb.25.945","volume":"25","author":"Y Nakamura","year":"2002","unstructured":"Nakamura Y: Regulating factors for microglial activation. Biol Pharm Bull. 2002, 25: 945-953. 10.1248\/bpb.25.945.","journal-title":"Biol Pharm Bull"},{"key":"59_CR9","first-page":"RA165","volume":"8","author":"A Czlonkowska","year":"2002","unstructured":"Czlonkowska A, Kurkowska-Jastrzebska I, Czlonkowski A, Peter D, Stefano GB: Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide. Med Sci Monit. 2002, 8: RA165-77.","journal-title":"Med Sci Monit"},{"key":"59_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0969-9961(02)00017-7","volume":"12","author":"T Arimoto","year":"2003","unstructured":"Arimoto T, Bing G: Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol Dis. 2003, 12: 35-45. 10.1016\/S0969-9961(02)00017-7.","journal-title":"Neurobiol Dis"},{"key":"59_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.035048","volume":"304","author":"B Liu","year":"2003","unstructured":"Liu B, Hong JS: Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2003, 304: 1-7. 10.1124\/jpet.102.035048.","journal-title":"J Pharmacol Exp Ther"},{"key":"59_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1749-6632.2003.tb07482.x","volume":"991","author":"P Teismann","year":"2003","unstructured":"Teismann P, Vila M, Choi DK, Tieu K, Wu DC, Jackson-Lewis V, Przedborski S: COX-2 and neurodegeneration in Parkinson's disease. Ann N Y Acad Sci. 2003, 991: 272-277.","journal-title":"Ann N Y Acad Sci"},{"key":"59_CR13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","volume":"63","author":"L Minghetti","year":"2004","unstructured":"Minghetti L: Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004, 63: 901-910.","journal-title":"J Neuropathol Exp Neurol"},{"key":"59_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0301-0082(97)00052-X","volume":"54","author":"L Minghetti","year":"1998","unstructured":"Minghetti L, Levi G: Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol. 1998, 54: 99-125. 10.1016\/S0301-0082(97)00052-X.","journal-title":"Prog Neurobiol"},{"key":"59_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.10332","volume":"18","author":"P Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Cohen O, Choi DK, Wu du C, Marks D, Vila M, Jackson-Lewis V, Przedborski S: Pathogenic role of glial cells in Parkinson's disease. Mov Disord. 2003, 18: 121-129. 10.1002\/mds.10332.","journal-title":"Mov Disord"},{"key":"59_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jemt.1120","volume":"54","author":"PJ Gebicke-Haerter","year":"2001","unstructured":"Gebicke-Haerter PJ: Microglia in neurodegeneration: molecular aspects. Microsc Res Tech. 2001, 54: 47-58. 10.1002\/jemt.1120.","journal-title":"Microsc Res Tech"},{"key":"59_CR17","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1096\/fj.04-2370com","volume":"19","author":"T Wang","year":"2005","unstructured":"Wang T, Pei Z, Zhang W, Liu B, Langenbach R, Lee C, Wilson B, Reece JM, Miller DS, Hong JS: MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration. Faseb J. 2005, 19: 1134-1136. 10.1096\/fj.04-2370com.","journal-title":"Faseb J"},{"key":"59_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","volume":"327","author":"M Etminan","year":"2003","unstructured":"Etminan M, Gill S, Samii A: Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. Bmj. 2003, 327: 128-10.1136\/bmj.327.7407.128.","journal-title":"Bmj"},{"key":"59_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","volume":"60","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hernan MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE, Ascherio A: Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol. 2003, 60: 1059-1064. 10.1001\/archneur.60.8.1059.","journal-title":"Arch Neurol"},{"key":"59_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0092-8674(95)90125-6","volume":"83","author":"SG Morham","year":"1995","unstructured":"Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 1995, 83: 473-482. 10.1016\/0092-8674(95)90125-6.","journal-title":"Cell"},{"key":"59_CR21","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1523\/JNEUROSCI.22-06-02246.2002","volume":"22","author":"PT Jantzen","year":"2002","unstructured":"Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN: Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci. 2002, 22: 2246-2254.","journal-title":"J Neurosci"},{"key":"59_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","volume":"14","author":"MJ West","year":"1993","unstructured":"West MJ: New stereological methods for counting neurons. Neurobiol Aging. 1993, 14: 275-285. 10.1016\/0197-4580(93)90112-O.","journal-title":"Neurobiol Aging"},{"key":"59_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0165-0270(98)00078-8","volume":"83","author":"G Rozas","year":"1998","unstructured":"Rozas G, Lopez-Martin E, Guerra MJ, Labandeira-Garcia JL: The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J Neurosci Methods. 1998, 83: 165-175. 10.1016\/S0165-0270(98)00078-8.","journal-title":"J Neurosci Methods"},{"key":"59_CR24","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1096\/fj.01-0390rev","volume":"15","author":"I Tegeder","year":"2001","unstructured":"Tegeder I, Pfeilschifter J, Geisslinger G: Cyclooxygenase-independent actions of cyclooxygenase inhibitors. Faseb J. 2001, 15: 2057-2072. 10.1096\/fj.01-0390rev.","journal-title":"Faseb J"},{"key":"59_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1749-6632.1999.tb08723.x","volume":"889","author":"ROBERT Langenbach","year":"1999","unstructured":"Langenbach ROBERT, LOFTIN CHARLESD, LEE CHRISTOPHER, TIANO HOWARD: Cyclooxygenase-deficient Mice: A Summary of Their Characteristics and Susceptibilities to Inflammation and Carcinogenesis. Ann NY Acad Sci. 1999, 889: 52-61. 10.1111\/j.1749-6632.1999.tb08723.x.","journal-title":"Ann NY Acad Sci"},{"key":"59_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0006-8993(02)04085-4","volume":"964","author":"S Sugama","year":"2003","unstructured":"Sugama S, Yang L, Cho BP, DeGiorgio LA, Lorenzl S, Albers DS, Beal MF, Volpe BT, Joh TH: Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL\/6 mice. Brain Res. 2003, 964: 288-294. 10.1016\/S0006-8993(02)04085-4.","journal-title":"Brain Res"},{"key":"59_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","volume":"39","author":"P Teismann","year":"2001","unstructured":"Teismann P, Ferger B: Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease. Synapse. 2001, 39: 167-174. 10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U.","journal-title":"Synapse"},{"key":"59_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0304-3940(02)00704-8","volume":"329","author":"ZH Feng","year":"2002","unstructured":"Feng ZH, Wang TG, Li DD, Fung P, Wilson BC, Liu B, Ali SF, Langenbach R, Hong JS: Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neuroscience Letters. 2002, 329: 354-358. 10.1016\/S0304-3940(02)00704-8.","journal-title":"Neuroscience Letters"},{"key":"59_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1353-8020(02)00021-4","volume":"8","author":"E Koutsilieri","year":"2002","unstructured":"Koutsilieri E, Scheller C, Tribl F, Riederer P: Degeneration of neuronal cells due to oxidative stress--microglial contribution. Parkinsonism Relat Disord. 2002, 8: 401-406. 10.1016\/S1353-8020(02)00021-4.","journal-title":"Parkinsonism Relat Disord"},{"key":"59_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.expneurol.2003.08.004","volume":"184","author":"A Hartmann","year":"2003","unstructured":"Hartmann A, Hunot S, Hirsch EC: Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter. Exp Neurol. 2003, 184: 561-564. 10.1016\/j.expneurol.2003.08.004.","journal-title":"Exp Neurol"},{"key":"59_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-2094-1-6","volume":"1","author":"R Sanchez-Pernaute","year":"2004","unstructured":"Sanchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell AL, Isacson O: Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J Neuroinflammation. 2004, 1: 6-10.1186\/1742-2094-1-6.","journal-title":"J Neuroinflammation"},{"key":"59_CR32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0306-4522(85)90095-8","volume":"16","author":"O Isacson","year":"1985","unstructured":"Isacson O, Brundin P, Gage FH, Bjorklund A: Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience. 1985, 16: 799-817. 10.1016\/0306-4522(85)90095-8.","journal-title":"Neuroscience"},{"key":"59_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/glia.20015","volume":"46","author":"C Barcia","year":"2004","unstructured":"Barcia C, Sanchez Bahillo A, Fernandez-Villalba E, Bautista V, Poza YPM, Fernandez-Barreiro A, Hirsch EC, Herrero MT: Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia. 2004, 46: 402-409. 10.1002\/glia.20015.","journal-title":"Glia"},{"key":"59_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ana.10728","volume":"54","author":"PL McGeer","year":"2003","unstructured":"McGeer PL, Schwab C, Parent A, Doudet D: Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol. 2003, 54: 599-604. 10.1002\/ana.10728.","journal-title":"Ann Neurol"},{"key":"59_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D: Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol. 1999, 46: 598-605. 10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F.","journal-title":"Ann Neurol"},{"key":"59_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0091-3057(99)00229-4","volume":"65","author":"B Ferger","year":"2000","unstructured":"Ferger B, Teismann P, Earl CD, Kuschinsky K, Oertel WH: The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping. Pharmacol Biochem Behav. 2000, 65: 425-431. 10.1016\/S0091-3057(99)00229-4.","journal-title":"Pharmacol Biochem Behav"},{"key":"59_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0014-2999(98)00696-7","volume":"360","author":"B Ferger","year":"1998","unstructured":"Ferger B, Spratt C, Teismann P, Seitz G, Kuschinsky K: Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo. Eur J Pharmacol. 1998, 360: 155-163. 10.1016\/S0014-2999(98)00696-7.","journal-title":"Eur J Pharmacol"},{"key":"59_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/PL00005264","volume":"358","author":"B Ferger","year":"1998","unstructured":"Ferger B, Spratt C, Earl CD, Teismann P, Oertel WH, Kuschinsky K: Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo. Naunyn Schmiedebergs Arch Pharmacol. 1998, 358: 351-359.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"59_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s002130051146","volume":"147","author":"S Shiozaki","year":"1999","unstructured":"Shiozaki S, Ichikawa S, Nakamura J, Kitamura S, Yamada K, Kuwana Y: Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology (Berl). 1999, 147: 90-95. 10.1007\/s002130051146.","journal-title":"Psychopharmacology (Berl)"},{"key":"59_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0006-8993(87)90120-X","volume":"403","author":"GA Ricaurte","year":"1987","unstructured":"Ricaurte GA, Irwin I, Forno LS, DeLanney LE, Langston E, Langston JW: Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res. 1987, 403: 43-51. 10.1016\/0006-8993(87)90120-X.","journal-title":"Brain Res"},{"key":"59_CR41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0306-4522(02)00572-9","volume":"116","author":"S Sugama","year":"2003","unstructured":"Sugama S, Cho BP, Degiorgio LA, Shimizu Y, Kim SS, Kim YS, Shin DH, Volpe BT, Reis DJ, Cho S, Joh TH: Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat. Neuroscience. 2003, 116: 925-933. 10.1016\/S0306-4522(02)00572-9.","journal-title":"Neuroscience"},{"key":"59_CR42","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","volume":"19","author":"S Hunot","year":"1999","unstructured":"Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debre P, Agid Y, Dugas B, Hirsch EC: FcepsilonRII\/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci. 1999, 19: 3440-3447.","journal-title":"J Neurosci"},{"key":"59_CR43","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1046\/j.1460-9568.2002.02290.x","volume":"16","author":"MJ Wang","year":"2002","unstructured":"Wang MJ, Lin WW, Chen HL, Chang YH, Ou HC, Kuo JS, Hong JS, Jeng KC: Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur J Neurosci. 2002, 16: 2103-2112. 10.1046\/j.1460-9568.2002.02290.x.","journal-title":"Eur J Neurosci"},{"key":"59_CR44","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","volume":"81","author":"HM Gao","year":"2002","unstructured":"Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B: Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem. 2002, 81: 1285-1297. 10.1046\/j.1471-4159.2002.00928.x.","journal-title":"J Neurochem"},{"key":"59_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","volume":"172","author":"G Boka","year":"1994","unstructured":"Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC: Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett. 1994, 172: 151-154. 10.1016\/0304-3940(94)90684-X.","journal-title":"Neurosci Lett"},{"key":"59_CR46","doi-asserted-by":"publisher","first-page":"10444","DOI":"10.1074\/jbc.M413863200","volume":"280","author":"H Takeuchi","year":"2005","unstructured":"Takeuchi H, Mizuno T, Zhang G, Wang J, Kawanokuchi J, Kuno R, Suzumura A: Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J Biol Chem. 2005, 280: 10444-10454. 10.1074\/jbc.M413863200.","journal-title":"J Biol Chem"},{"key":"59_CR47","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1023\/A:1007048903862","volume":"28","author":"J Schiefer","year":"1999","unstructured":"Schiefer J, Kampe K, Dodt HU, Zieglgansberger W, Kreutzberg GW: Microglial motility in the rat facial nucleus following peripheral axotomy. J Neurocytol. 1999, 28: 439-453. 10.1023\/A:1007048903862.","journal-title":"J Neurocytol"},{"key":"59_CR48","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0306-4522(97)00424-7","volume":"83","author":"BT Volpe","year":"1998","unstructured":"Volpe BT, Wildmann J, Altar CA: Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions. Neuroscience. 1998, 83: 741-748. 10.1016\/S0306-4522(97)00424-7.","journal-title":"Neuroscience"},{"key":"59_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2","volume":"19","author":"L Minghetti","year":"1997","unstructured":"Minghetti L, Nicolini A, Polazzi E, Creminon C, Maclouf J, Levi G: Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia. 1997, 19: 152-160. 10.1002\/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2.","journal-title":"Glia"},{"key":"59_CR50","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C","volume":"55","author":"AH Stokes","year":"1999","unstructured":"Stokes AH, Hastings TG, Vrana KE: Cytotoxic and genotoxic potential of dopamine. J Neurosci Res. 1999, 55: 659-665. 10.1002\/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C.","journal-title":"J Neurosci Res"},{"key":"59_CR51","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","volume":"64","author":"TG Hastings","year":"1995","unstructured":"Hastings TG: Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem. 1995, 64: 919-924.","journal-title":"J Neurochem"},{"key":"59_CR52","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S: Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci. 2002, 22: 1763-1771.","journal-title":"J Neurosci"},{"key":"59_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0006-8993(02)04174-4","volume":"966","author":"K Sairam","year":"2003","unstructured":"Sairam K, Saravanan KS, Banerjee R, Mohanakumar KP: Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Brain Res. 2003, 966: 245-252. 10.1016\/S0006-8993(02)04174-4.","journal-title":"Brain Res"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-3-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T16:19:44Z","timestamp":1706977184000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-3-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,27]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-3-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,27]]},"assertion":[{"value":"18 January 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}